Bone marrow–derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction.

Slides:



Advertisements
Similar presentations
Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial Infarction 
Advertisements

The N-methyl-D -aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: A study in the chronic porcine model 
Manuel J. Antunes, MD, PhD, DSc 
Leukocyte filtration to decrease the number of adherent leukocytes in the cerebral microcirculation after a period of deep hypothermic circulatory arrest 
In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates?  Andre Vincentelli,
Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Hajime.
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis 
Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathy  Mohamed Salama, MD, PhD, Olena Andrukhova, PhD, Susanne Roedler,
Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal.
Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac.
Hybrid Surgical Angiogenesis: Omentopexy Can Enhance Myocardial Angiogenesis Induced by Cell Therapy  Taro Kanamori, MD, Go Watanabe, MD, Tamotsu Yasuda,
Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial Infarction 
Regulatory T cells enhance mesenchymal stem cell survival and proliferation following autologous cotransplantation in ischemic myocardium  Yifu Zhou,
The reduction of hemodynamic loading assists self-regeneration of the injured heart by increasing cell proliferation, inhibiting cell apoptosis, and inducing.
Allogeneic Mesenchymal Precursor Cell Therapy to Limit Remodeling After Myocardial Infarction: The Effect of Cell Dosage  Hirotsugu Hamamoto, MD, Joseph.
Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction  Tamotsu Yasuda, MD, PhD, Richard D. Weisel,
Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Changfa Guo, MD, Husnain Kh. Haider, PhD, Winston S. N
Transgenic model of cardiac rhabdomyosarcoma formation
Hypertonic Saline Dextran Improves Outcome After Hypothermic Circulatory Arrest: A Study in a Surviving Porcine Model  Timo Kaakinen, MD, Hanna Alaoja,
Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic.
Persistence of marrow stromal cells implanted into acutely infarcted myocardium: Observations in a xenotransplant model  Derek J. MacDonald, MD, Jun Luo,
Biodegradable elastic patch plasty ameliorates left ventricular adverse remodeling after ischemia–reperfusion injury: A preclinical study of a porous.
Building a bioartificial heart: A 3-song saga
Cold retrograde cerebral perfusion improves cerebral protection during moderate hypothermic circulatory arrest: A long-term study in a porcine model 
Effects of pH Management During Selective Antegrade Cerebral Perfusion on Cerebral Microcirculation and Metabolism: Alpha-Stat Versus pH-Stat  Sebastian.
A novel vascularized patch enhances cell survival and modifies ventricular remodeling in a rat myocardial infarction model  Qi Zhou, MD, PhD, Jian-Ye.
Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction  Jiang-Yong Min, MD, Xuling Huang, MD,
Intrinsic cardiac stem cells are essential for regeneration
Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle  Theo Kofidis, MD,
Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure  Mark F. Berry, MD, Timothy.
CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair  N.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function 
William M. DeCampli, MD, PhD 
Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: Heart status and cell distribution  Hao Zhang, MD, PhD,
Recombinant human hepatocyte growth factor transfection alleviates hyperkinetic pulmonary artery hypertension in rabbit models  Wei Wang, MD, Kai Liu,
Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor  Matthias.
The lord of the rings  Antonio Miceli, MD, PhD 
Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model  Yasuhiro.
Potential neuroprotective benefits of erythropoietin during experimental hypothermic circulatory arrest  Pekka Romsi, MDa, Erkka Rönkä, MSa, Kai Kiviluoma,
Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia/reperfusion  Aditya K. Kaza, MD, Isaac Wamala, MD, Ingeborg.
Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation  Shinji Tomita, MD, PhD, Donald.
Sinus node structural changes in patients with long-standing chronic atrial fibrillation  Aquilino Hurlé, MD, PhD, Vicente Climent, MD, PhD, Damian Sánchez-Quintana,
Leukocyte filtration to decrease the number of adherent leukocytes in the cerebral microcirculation after a period of deep hypothermic circulatory arrest 
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
The tissue-engineered vascular graft using bone marrow without culture
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
A first start for lung transplantation?
Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy  Jiashing Yu,
A fate worse than death  Jennifer S. Lawton, MD 
Demonstration of the skip metastasis pathway for N2 non–small cell lung cancer  Hiromitsu Takizawa, MD, Shoji Sakiyama, MD, Mitsuhiro Tsuboi, MD, Akira.
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Lamotrigine improves cerebral outcome after hypothermic circulatory arrest: A study in a chronic porcine model  Vesa Anttila, MDa, Jussi Rimpiläinen,
Prognosis and “granularity”: Building on staging foundations?
Nonintubated thoracoscopic surgery for pulmonary lesions in both lungs
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Implantation of fetal rat lung fragments into bleomycin-induced pulmonary fibrosis  Hiroaki Toba, MD, Shoji Sakiyama, MD, PhD, Koichiro Kenzaki, MD, PhD,
“The more things change…”: The challenges ahead
Optimizing cardiac cell therapy: From processing to delivery
Did you like Terminator 3 better than Terminator 2
Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks!  W. Hampton Gray, MD, P. Michael.
Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer  Chengwu.
Presentation transcript:

Bone marrow–derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site  Jussi Mäkelä, BM, Kari Ylitalo, MD, PhD, Siri Lehtonen, PhD, Sebastian Dahlbacka, MD, Eija Niemelä, BM, Kai Kiviluoma, MD, PhD, Jussi Rimpiläinen, MD, PhD, Hanna Alaoja, BM, Timo Paavonen, MD, PhD, Petri Lehenkari, MD, PhD, Tatu Juvonen, MD, PhD, Vesa Anttila, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 134, Issue 3, Pages 565-573 (September 2007) DOI: 10.1016/j.jtcvs.2007.05.004 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Bone marrow–derived mononuclear cell (BMMC) injection at the infarction site enables ejection fraction recovery. The ejection fraction decreased after infarction critically (>15%) in both groups (!P = .03). After the 3-week recovery period, the ejection fraction increased significantly in the BMMC group (*P = .02) but remained at the same decreased level in the control group. Data points represent actual median values ± standard deviation. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 565-573DOI: (10.1016/j.jtcvs.2007.05.004) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Injected DiI-labeled cells remain at the infarct site. Transplanted DiI-labeled (white arrows) cells were detected by using a fluorescent microscope (magnification ×20) from the infarcted area (A) and from some of the perihilar lymph nodes (B). A sample from undamaged heart muscle was negative (C), as were samples from the liver (D), spleen (E), and lungs (F). Bars = 100 μm. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 565-573DOI: (10.1016/j.jtcvs.2007.05.004) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Injected DiI-labeled cells differentiate at the injection site. DiI-positive cells in the granulation tissue area at the infarcted myocardium showed positive expression of α-smooth muscle actin (α-SMA; A and B), Ki-67 (C and D; magnification ×20), vimentin (E and F; magnification ×40), and muscle-specific actin (MSA; G and H; magnification ×60). Bars = 20 μm. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 565-573DOI: (10.1016/j.jtcvs.2007.05.004) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Injection of bone marrow–derived mononuclear cells (BMMC) enhances cell survival and recruitment at the infarction site parenchyma. Larger quantities of living cells in the necrotic area were observed with a fluorescent microscope (magnification ×20) in the BMMC group by using Hoechst staining (A and B) compared with the control group (E and F). In cell counting a significant difference between the groups could readily be observed (I; ***P < .001). Similarly, a larger number of Stro-1–positive cells was detected in the BMMC group (C, D, and J; P < .001) compared with the control group (G and H). The highest density of Stro-1–positive cells was detected at the vessel walls in the BMMC group (D) in contrast to the control group (H). Bars in A, C, E, and G = 100 μm; bars in B, D, F, and H = 20 μm. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 565-573DOI: (10.1016/j.jtcvs.2007.05.004) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Injection of bone marrow–derived mononuclear cells (BMMC) promotes postinfarction remodeling. Analysis of the immunohistologic staining with a light microscope revealed differences between the control and BMMC groups (images with ×10 magnification are shown). Enhanced vimentin staining (A and C), indicating a larger quantity of mesenchymal cells in the necrotic area (E; P < .01) and in the border zone (F; P < .001), could be seen in the BMMC group. For the muscle actin staining (B and D), the proportional area of cell coverage was greater in the granulation tissue area (G) in the BMMC group (P = .035). Bars = 50 μm. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 565-573DOI: (10.1016/j.jtcvs.2007.05.004) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions